Procter & Gamble Health Limited — Important, 13-02-2025: Updates

The Board of Directors of Procter & Gamble Health Limited has declared an interim dividend of ₹80 per equity share for the financial year 2024-25. This dividend will be distributed to shareholders registered by the close of business hours on the record date. Shareholders are advised to provide relevant details, including Permanent Account Number (PAN), to ensure correct TDS (tax deducted at source) rates are applied. The TDS is mandated as per the provisions of the Income Tax Act, 1961, with specific requirements varying for resident and non-resident shareholders. Resident shareholders may benefit from reduced TDS if certain forms are submitted, while non-resident shareholders must provide additional documentation to claim benefits under Double Taxation Avoidance Agreements. The Company emphasizes compliance, urging shareholders to submit necessary forms by the stated deadlines to avoid higher tax deductions. Overall, it indicates a structured approach to dividend distribution, balancing regulatory compliance and shareholder benefits.